United States · Bill · HR
H.R. 7497 (93rd)
Prescription Drug Patent Licensing Act
Introduced
3 May 1973
Last action
3 May 1973 · Introduced
Status
Referred to House Committee on Judiciary.
Sponsors
Rep. Rosenthal, Benjamin S. [D-NY-8], Rep. Abzug, Bella S. [D-NY-20], Rep. Badillo, Herman [D-NY-21], Rep. Bingham, Jonathan B. [D-NY-22], Rep. Brasco, Frank [D-NY-11], Rep. Brown, George E., Jr. [D-CA-42], Rep. Burton, Phillip [D-CA-6], Rep. Chisholm, Shirley [D-NY-12], Rep. Conyers, John, Jr. [D-MI-13], Rep. Corman, James C. [D-CA-21], Rep. Diggs, Charles C., Jr. [D-MI-13], Rep. Edwards, Don [D-CA-10], Rep. Harrington, Michael J. [D-MA-6], Rep. Hawkins, Augustus F. [D-CA-29], Rep. Hechler, Ken [D-WV-4], Rep. Koch, Edward I. [D-NY-18], Rep. McCormack, Mike [D-WA-4], Rep. Moakley, John Joseph [D-MA-9], Rep. Podell, Bertram L. [D-NY-13], Rep. Rees, Thomas M. [D-CA-23], Rep. Roybal, Edward R. [D-CA-25], Rep. Seiberling, John F. [D-OH-14], Rep. Stark, Fortney Pete [D-CA-13], Rep. Stokes, Louis [D-OH-11], Del. Won Pat, Antonio B. [D-GU-At Large]
Subjects
Discovery layer
Source updated
3 September 2025
Summary
Prescription Drug Patent Licensing Act - Requires that, whenever the Federal Trade Commission, upon complaint made to it by a qualified applicant for a license under a drug patent determines through an investigation and hearing that such application for a license was not granted and that the price quoted to druggists by the patentee is more than 500 percent of the total cost of production, the Commission shall order such patentee to grant an unrestricted license to any qualified applicant to make, use, and sell such drug. States that the Commission may delay such order up to five years to provide a fair return on the patentee's invested capital. (Adds 35 U.S.C. 294)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 May 1973
Introduced
Referred to House Committee on Judiciary.
Source: IntroReferral
3 May 1973
Introduced
Introduced in House
Source: IntroReferral
3 May 1973
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 3 May 1973
Sponsors
- Rep. Rosenthal, Benjamin S. [D-NY-8] · D · Sponsor
- Rep. Abzug, Bella S. [D-NY-20] · D · Cosponsor
- Rep. Badillo, Herman [D-NY-21] · D · Cosponsor
- Rep. Bingham, Jonathan B. [D-NY-22] · D · Cosponsor
- Rep. Brasco, Frank [D-NY-11] · D · Cosponsor
- Rep. Brown, George E., Jr. [D-CA-42] · D · Cosponsor
- Rep. Burton, Phillip [D-CA-6] · D · Cosponsor
- Rep. Chisholm, Shirley [D-NY-12] · D · Cosponsor
- Rep. Conyers, John, Jr. [D-MI-13] · D · Cosponsor
- Rep. Corman, James C. [D-CA-21] · D · Cosponsor
- Rep. Diggs, Charles C., Jr. [D-MI-13] · D · Cosponsor
- Rep. Edwards, Don [D-CA-10] · D · Cosponsor
- Rep. Harrington, Michael J. [D-MA-6] · D · Cosponsor
- Rep. Hawkins, Augustus F. [D-CA-29] · D · Cosponsor
- Rep. Hechler, Ken [D-WV-4] · D · Cosponsor
- Rep. Koch, Edward I. [D-NY-18] · D · Cosponsor
- Rep. McCormack, Mike [D-WA-4] · D · Cosponsor
- Rep. Moakley, John Joseph [D-MA-9] · D · Cosponsor
- Rep. Podell, Bertram L. [D-NY-13] · D · Cosponsor
- Rep. Rees, Thomas M. [D-CA-23] · D · Cosponsor
- Rep. Roybal, Edward R. [D-CA-25] · D · Cosponsor
- Rep. Seiberling, John F. [D-OH-14] · D · Cosponsor
- Rep. Stark, Fortney Pete [D-CA-13] · D · Cosponsor
- Rep. Stokes, Louis [D-OH-11] · D · Cosponsor
- Del. Won Pat, Antonio B. [D-GU-At Large] · D · Cosponsor
- · hsju00 · Standing
Related records
- related to → Prescription Drug Patent Licensing Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/93rd-congress/house-bill/7497
- Open data entity: https://api.congress.gov/v3/bill/93/hr/7497
- us · 93-hr-7497 · source updated 3 September 2025